Cook Medical Sizing Catheters Removed Due to Risk of Device Breakage
The U.S. Food and Drug Administration (FDA) has issued an early alert regarding a potentially serious device issue involving certain sizing catheters manufactured by Cook Medical.
Cook Medical has notified customers to immediately remove affected products from use and distribution due to a risk of device component failure that could result in patient harm.
Affected Devices
The recall involves Centimeter Sizing Catheters, Aurous Centimeter Sizing Catheters, and Beacon Tip Centimeter Sizing Catheters. Download a full list of affected product lots by clicking on the download link in the right column of this page.
Device Use
Sizing catheters are used in angiographic procedures by trained physicians to navigate vascular anatomy, accurately position devices, and measure anatomical structures.
They are available in lengths of 70 cm and 100 cm, and tip configurations including straight, PIG, and VCF.
Reason for the Alert
Cook Medical identified that marker bands on the affected catheters may be prone to cracking or breakage.
These marker bands are critical for device positioning and anatomical orientation during angiographic procedures
Potential Risks to Patients
If a device failure occurs, potential adverse events may include increased procedural time, device fragmentation or separation, vessel injury, and the need for additional intervention.
In severe cases, device fragmentation could lead to life-threatening complications or death.
As of April 2, no serious injuries or deaths have been reported.
Required Actions for Healthcare Providers
Cook Medical has instructed customers to take the following steps immediately.
Identify and Quarantine
Review inventory for affected products and remove then isolate any impacted devices.
Cease Use and Distribution
Do not use affected catheters and stop any further distribution.
Return Affected Products
Return affected products to Cook Medical.
Notify Internal and External Stakeholders
Inform all relevant personnel and any facilities that received the devices.
Report Adverse Events
Adverse events or quality issues should be reported to Cook Medical by phone at 800.457.4500 / 812.339.2235, or by email at CustomerRelationsNA@CookMedical.com.
Healthcare providers may also report events through the FDA’s MedWatch program.
Regulatory Status
The FDA is currently evaluating this issue and has classified it as an early alert, indicating a potentially high-risk device concern. Further updates will be provided as additional information becomes available.
MDP Insight
This event highlights several critical quality system considerations. Supplier and component control failures can directly impact device integrity. Design robustness and material durability must be validated under real-world conditions. Postmarket surveillance systems must detect early signals of failure, and CAPA systems must rapidly assess and mitigate risk.
Marker band failure represents an intersection between design, manufacturing, and risk management.
Key Takeaway
Even seemingly minor components like marker bands can create significant clinical risk if they fail. This reinforces the importance of comprehensive design validation, robust supplier controls, and effective postmarket monitoring.
Links
Read the FDA’s announcement here.
Download the List of Affected Products
Intersurgical 22mm Smoothbore Breathing Tubes and Systems
FDA Issues Early Alert for Intersurgical Breathing Systems Over Potential Ventilation Failure. Manufacturing defect may cause breathing tube connectors to separate during use, potentially interrupting ventilation and exposing patients to serious injury or death.The...
FDA Early Alert: Teleflex/Arrow Guidewire
Affected guidewires and catheter products may release hydrophilic polymer particles into the bloodstream, potentially causing serious injury or death. No serious injuries or deaths have been reported.The U.S. Food and Drug Administration (FDA) has issued an Early...
FDA Investigates Cancer Risk with Zolgensma Gene Therapy
Postmarketing reports identify cases of tumor formation linked to gene therapy vector integration, prompting FDA to evaluate potential regulatory action.The U.S. Food and Drug Administration (FDA) is investigating a serious potential cancer risk associated with...
Eugia Vancomycin Recall: Glass Particle Contamination
FDA announces voluntary recall of a single lot of vancomycin hydrochloride for injection because of potentially dangerous particulate contamination.Eugia US LLC, formerly Auro Medics Pharma LLC, has initiated a voluntary nationwide recall of one lot of Vancomycin...
FDA Requires New GLP-1 Drug Warning for Vision Loss Risk
Agency cites potential increased risk of rare optic nerve condition following review of clinical trials and postmarket safety dataThe U.S. Food and Drug Administration (FDA) is requiring manufacturers of all glucagon-like peptide-1 receptor agonist (GLP-1 RA)...
Class 1 Recall for HemosIL AcuStar HIT Antibody Test
HemosIL AcuStar HIT-IgG(PF4-H). Source: fda.govPerformance problems could produce false-negative results, potentially delaying diagnosis of a dangerous reaction to heparin.The U.S. Food and Drug Administration (FDA) has identified a recall of certain lots of the...